At a glance
ClinicalIndex Comparison RecordN/ACompleted· 225 enrolled
Drug / intervention
Restylane Contourdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, No-treatment-controlled, Evaluator-blinded, Multi-center Study to Evaluate the Effectiveness and Safety of Restylane Contour in the Treatment of Temple Hollowing
In Brief
A clinical study evaluating Restylane Contour for Temporal Hollowing. Completed, enrolled 225 participants across 15 sites.
Detailed Summary
This is a randomized, no-treatment-controlled, evaluator-blinded, multi-center study to evaluate the effectiveness and safety of Restylane® Contour in correction of temple hollowing.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTemporal Hollowing
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
First PostedJan 2023
Enrollment StartMar 2023
Primary CompletionOct 2023
Study CompletionDec 2024
TodayJul 2026
First PostedJan 20, 2023
Enrollment StartMar 14, 2023
Primary CompletionOct 26, 2023
Study CompletionDec 11, 2024
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 3.4 years ago
Interventions
Restylane Contourdevice
a sterile, biodegradable, transparent gel of nonanimal cross-linked HA (20 mg/mL) with the addition of lidocaine hydrochloride (3 mg/mL)